{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:33:34Z","timestamp":1780472014628,"version":"3.54.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","prd-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.parkreldis.2024.107212","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T21:35:21Z","timestamp":1732052121000},"page":"107212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Exposure factors and clinical characteristics associated with Parkinson's disease in GBA1 variant carriers: A Chinese GBA1-PD intrafamilial survey"],"prefix":"10.1016","volume":"130","author":[{"given":"Xuxiang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peishan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxiang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beisha","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3658-3928","authenticated-orcid":false,"given":"Jifeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.parkreldis.2024.107212_bib1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","article-title":"Prodromal Parkinson disease subtypes - key to understanding heterogeneity","volume":"17","author":"Berg","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.parkreldis.2024.107212_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41582-021-00489-6","article-title":"Prodromal Parkinson disease - time is brain","volume":"17","author":"Weber","year":"2021","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2024.107212_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/jamaneurol.2022.3902","article-title":"Widening the spectrum of risk factors, comorbidities, and prodromal features of Parkinson disease","volume":"80","author":"Schrag","year":"2023","journal-title":"JAMA Neurol."},{"issue":"17","key":"10.1016\/j.parkreldis.2024.107212_bib4","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107212_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41531-023-00571-4","article-title":"Mutational spectrum and clinical features of GBA1 variants in a Chinese cohort with Parkinson's disease","volume":"9","author":"Zhou","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.parkreldis.2024.107212_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2016.04.022","article-title":"Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden","volume":"45","author":"Ran","year":"2016","journal-title":"Neurobiol. Aging"},{"issue":"5","key":"10.1016\/j.parkreldis.2024.107212_bib7","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.parkreldis.2011.11.028","article-title":"Glucocerebrosidase N370S and L444P mutations as risk factors for Parkinson's disease in Brazilian patients","volume":"18","author":"Guimaraes Bde","year":"2012","journal-title":"Parkinsonism Relat. Disorders"},{"issue":"3","key":"10.1016\/j.parkreldis.2024.107212_bib8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1212\/WNL.0b013e318207b01e","article-title":"Mutations in the glucocerebrosidase gene confer a risk for Parkinson disease in North Africa","volume":"76","author":"Lesage","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2024.107212_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114402","article-title":"Lysosomal functions and dysfunctions: molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease","volume":"187","author":"Horowitz","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.parkreldis.2024.107212_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108419","article-title":"Targeting the GBA1 pathway to slow Parkinson disease: insights into clinical aspects, pathogenic mechanisms and new therapeutic avenues","volume":"246","author":"Menozzi","year":"2023","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.parkreldis.2024.107212_bib11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/mds.29314","article-title":"Classification of GBA1 variants in Parkinson's disease: the GBA1-PD browser","volume":"38","author":"Parlar","year":"2023","journal-title":"Mov. Disord."},{"issue":"11","key":"10.1016\/j.parkreldis.2024.107212_bib12","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1002\/mds.28200","article-title":"Penetrance of glucocerebrosidase (GBA) mutations in Parkinson's disease: a kin cohort study","volume":"35","author":"Balestrino","year":"2020","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.parkreldis.2024.107212_bib13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1212\/WNL.0b013e318245f476","article-title":"Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers","volume":"78","author":"Anheim","year":"2012","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.parkreldis.2024.107212_bib14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11910-023-01259-1","article-title":"Who is at risk of Parkinson disease? Refining the preclinical phase of GBA1 and LRRK2 variant carriers: a clinical, biochemical, and imaging approach","volume":"23","author":"Menozzi","year":"2023","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"6","key":"10.1016\/j.parkreldis.2024.107212_bib15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/mds.27720","article-title":"Environment, lifestyle, and Parkinson's disease: implications for prevention in the next decade","volume":"34","author":"Marras","year":"2019","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107212_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mds.26904","article-title":"Note: the 200th anniversary of the shaking palsy","volume":"32","author":"Obeso","year":"2017","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107212_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s40035-023-00392-8","article-title":"Parkinson's disease and gut microbiota: from clinical to mechanistic and therapeutic studies","volume":"12","author":"Zhang","year":"2023","journal-title":"Transl. Neurodegener."},{"issue":"6646","key":"10.1016\/j.parkreldis.2024.107212_bib18","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1126\/science.adi7660","article-title":"Solvent exposure strongly linked to Parkinson's","volume":"380","author":"Wadman","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.parkreldis.2024.107212_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.172838","article-title":"Literature review and meta-analysis of environmental toxins associated with increased risk of Parkinson's disease","volume":"931","author":"Aravindan","year":"2024","journal-title":"Sci. Total Environ."},{"issue":"2","key":"10.1016\/j.parkreldis.2024.107212_bib20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/mds.29707","article-title":"Clearing the smoke: what protects smokers from Parkinson's disease?","volume":"39","author":"Rose","year":"2024","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.parkreldis.2024.107212_bib21","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/mds.27802","article-title":"Update of the MDS research criteria for prodromal Parkinson's disease","volume":"34","author":"Heinzel","year":"2019","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.parkreldis.2024.107212_bib22","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/mds.29037","article-title":"Collaborative Network in, the Chinese Parkinson's disease registry (CPDR): study design and baseline patient characteristics","volume":"37","author":"Zhou","year":"2022","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.parkreldis.2024.107212_bib23","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1038\/s41591-023-02440-2","article-title":"Wearable movement-tracking data identify Parkinson's disease years before clinical diagnosis","volume":"29","author":"Schalkamp","year":"2023","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.parkreldis.2024.107212_bib24","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/mds.27616","article-title":"Predicting diagnosis of Parkinson's disease: a risk algorithm based on primary care presentations","volume":"34","author":"Schrag","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2024.107212_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2022.107613","article-title":"Epidemiology meets toxicogenomics: mining toxicologic evidence in support of an untargeted analysis of pesticides exposure and Parkinson's disease","volume":"170","author":"Paul","year":"2022","journal-title":"Environ. Int."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107212_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41531-023-00615-9","article-title":"Towards improved screening of toxins for Parkinson's risk","volume":"9","author":"Shan","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"issue":"3","key":"10.1016\/j.parkreldis.2024.107212_bib27","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1289\/ehp.1103881","article-title":"Is pesticide use related to Parkinson disease? Some clues to heterogeneity in study results","volume":"120","author":"van der Mark","year":"2012","journal-title":"Environ. Health Perspect."},{"issue":"3","key":"10.1016\/j.parkreldis.2024.107212_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5271\/sjweh.3641","article-title":"Parkinson's disease and occupational exposures: a systematic literature review and meta-analyses","volume":"43","author":"Gunnarsson","year":"2017","journal-title":"Scand. J. Work. Environ. Health"},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107212_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1515\/reveh-2021-0111","article-title":"Exposure to toxic occupations and their association with Parkinson's disease: a systematic review with meta-analysis","volume":"38","author":"Chambers-Richards","year":"2023","journal-title":"Rev. Environ. Health"},{"issue":"5","key":"10.1016\/j.parkreldis.2024.107212_bib30","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/mds.29012","article-title":"Exposure to pesticides predicts prodromal feature of Parkinson's disease: public health implications","volume":"37","author":"Darweesh","year":"2022","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2024.107212_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102340","article-title":"Understanding role of pesticides in development of Parkinson's disease: insights from Drosophila and rodent models","volume":"98","author":"Afsheen","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.parkreldis.2024.107212_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2022.113018","article-title":"A time-course study of microglial activation and dopaminergic neuron loss in the substantia nigra of mice with paraquat-induced Parkinson's disease","volume":"164","author":"Yang","year":"2022","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.parkreldis.2024.107212_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2022.107512","article-title":"Paraquat exposure induces Parkinsonism by altering lipid profile and evoking neuroinflammation in the midbrain","volume":"169","author":"Tong","year":"2022","journal-title":"Environ. Int."},{"key":"10.1016\/j.parkreldis.2024.107212_bib34","article-title":"Smoking exposure and Parkinson's disease: a UK Brain Bank pathology-validated case-control study","volume":"125","author":"di Biase","year":"2024","journal-title":"Parkinsonism Relat. Disorders"},{"issue":"20","key":"10.1016\/j.parkreldis.2024.107212_bib35","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1212\/WNL.0000000000009431","article-title":"Tobacco smoking and the reduced risk of Parkinson disease: a puzzle of 60 years","volume":"94","author":"Cheng","year":"2020","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.parkreldis.2024.107212_bib36","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1212\/01.wnl.0000256374.50227.4b","article-title":"Temporal relationship between cigarette smoking and risk of Parkinson disease","volume":"68","author":"Thacker","year":"2007","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.parkreldis.2024.107212_bib37","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1212\/WNL.0b013e3181d55f38","article-title":"Smoking duration, intensity, and risk of Parkinson disease","volume":"74","author":"Chen","year":"2010","journal-title":"Neurology"},{"issue":"20","key":"10.1016\/j.parkreldis.2024.107212_bib38","doi-asserted-by":"crossref","first-page":"e2132","DOI":"10.1212\/WNL.0000000000009437","article-title":"Tobacco smoking and the risk of Parkinson disease: a 65-year follow-up of 30,000 male British doctors","volume":"94","author":"Mappin-Kasirer","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2024.107212_bib39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40035-017-0090-8","article-title":"Nicotine from cigarette smoking and diet and Parkinson disease: a review","volume":"6","author":"Ma","year":"2017","journal-title":"Transl. Neurodegener."},{"issue":"3","key":"10.1016\/j.parkreldis.2024.107212_bib40","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3233\/JPD-202522","article-title":"Neuroticism, smoking, and the risk of Parkinson's disease","volume":"11","author":"Sieurin","year":"2021","journal-title":"J. Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107212_bib41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3233\/JPD-212851","article-title":"Environment in Parkinson's disease, mendelian randomisation study of smoking, alcohol, and coffee drinking in relation to Parkinson's disease","volume":"12","author":"Domenighetti","year":"2022","journal-title":"J. Parkinsons Dis."},{"issue":"8","key":"10.1016\/j.parkreldis.2024.107212_bib42","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/mds.25028","article-title":"Nicotine as a potential neuroprotective agent for Parkinson's disease","volume":"27","author":"Quik","year":"2012","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2024.107212_bib43","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/mds.27933","article-title":"Alcohol intake and Parkinson's disease risk in the million women study","volume":"35","author":"Kim","year":"2020","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.parkreldis.2024.107212_bib44","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/mds.28039","article-title":"Alcohol consumption and risk of Parkinson's disease: data from a large prospective European cohort","volume":"35","author":"Peters","year":"2020","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.parkreldis.2024.107212_bib45","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s00415-018-9032-3","article-title":"Alcohol consumption and risk for Parkinson's disease: a systematic review and meta-analysis","volume":"266","author":"Jimenez-Jimenez","year":"2019","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107212_bib46","doi-asserted-by":"crossref","first-page":"7496","DOI":"10.1038\/s41467-022-34732-5","article-title":"Genome-wide association study of REM sleep behavior disorder identifies polygenic risk and brain expression effects","volume":"13","author":"Krohn","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.parkreldis.2024.107212_bib47","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jamaneurol.2014.2950","article-title":"Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort","volume":"72","author":"Beavan","year":"2015","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107212_bib48","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41531-024-00706-1","article-title":"Longitudinal cognitive decline characterizes the profile of non-PD-manifest GBA1 mutation carriers","volume":"10","author":"Roeben","year":"2024","journal-title":"NPJ Parkinsons Dis."},{"issue":"9","key":"10.1016\/j.parkreldis.2024.107212_bib49","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/mds.27775","article-title":"Evolution and clustering of prodromal parkinsonian features in GBA1 carriers","volume":"34","author":"Mullin","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2024.107212_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.635958","article-title":"Cognitive functioning of glucocerebrosidase (GBA) non-manifesting carriers","volume":"12","author":"Moran","year":"2021","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107212_bib51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1474-4422(19)30319-9","article-title":"Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study","volume":"19","author":"Simuni","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2024.107212_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106343","article-title":"Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: the RAPSODI study","volume":"188","author":"Toffoli","year":"2023","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107212_bib53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40035-022-00294-1","article-title":"Genetic heterogeneity on sleep disorders in Parkinson's disease: a systematic review and meta-analysis","volume":"11","author":"Huang","year":"2022","journal-title":"Transl. Neurodegener."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107212_bib54","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41531-021-00219-1","article-title":"Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patients","volume":"7","author":"Baldelli","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"issue":"4","key":"10.1016\/j.parkreldis.2024.107212_bib55","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/ene.13776","article-title":"Patient's perception: shorter and more severe prodromal phase in GBA-associated PD","volume":"26","author":"Zimmermann","year":"2019","journal-title":"Eur. J. Neurol."},{"issue":"9","key":"10.1016\/j.parkreldis.2024.107212_bib56","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1212\/WNL.0000000000001315","article-title":"Differential effects of severe vs mild GBA mutations on Parkinson disease","volume":"84","author":"Gan-Or","year":"2015","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.parkreldis.2024.107212_bib57","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/mds.28195","article-title":"GBA-related Parkinson's disease: dissection of genotype-phenotype correlates in a large Italian cohort","volume":"35","author":"Petrucci","year":"2020","journal-title":"Mov. Disord."},{"issue":"7","key":"10.1016\/j.parkreldis.2024.107212_bib58","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/jnnp-2020-322857","article-title":"Impact of GBA1 variants on long-term clinical progression and mortality in incident Parkinson's disease","volume":"91","author":"Stoker","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.parkreldis.2024.107212_bib59","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.neuron.2019.12.004","article-title":"Glucocerebrosidase activity modulates neuronal susceptibility to pathological alpha-synuclein insult","volume":"105","author":"Henderson","year":"2020","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107212_bib60","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40035-024-00437-6","article-title":"Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson's disease","volume":"13","author":"Zhang","year":"2024","journal-title":"Transl. Neurodegener."},{"issue":"1","key":"10.1016\/j.parkreldis.2024.107212_bib61","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/mds.28818","article-title":"Clinical and dopamine transporter imaging trajectories in a cohort of Parkinson's disease patients with GBA mutations","volume":"37","author":"Caminiti","year":"2022","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.parkreldis.2024.107212_bib62","article-title":"Comparing the effects of GBA variants and onset age on clinical features and progression in Parkinson's disease, CNS Neurosci","volume":"30","author":"Ren","year":"2024","journal-title":"Ther."},{"issue":"10","key":"10.1016\/j.parkreldis.2024.107212_bib63","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/jamaneurol.2016.2245","article-title":"Association of GBA mutations and the E326K polymorphism with motor and cognitive progression in Parkinson disease","volume":"73","author":"Davis","year":"2016","journal-title":"JAMA Neurol."},{"issue":"8","key":"10.1016\/j.parkreldis.2024.107212_bib64","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/mds.23009","article-title":"Glucocerebrosidase gene L444P mutation is a risk factor for Parkinson's disease in Chinese population","volume":"25","author":"Sun","year":"2010","journal-title":"Mov. Disord."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802024012240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802024012240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T13:49:16Z","timestamp":1735739356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802024012240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":64,"alternative-id":["S1353802024012240"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2024.107212","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exposure factors and clinical characteristics associated with Parkinson's disease in GBA1 variant carriers: A Chinese GBA1-PD intrafamilial survey","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2024.107212","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107212"}}